| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 05/08/2012 | US8173360 Cell death inhibitor |
| 05/03/2012 | US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2012 | EP1955697B1 2-aminobenzamide derivatives as vanilloid receptor 1 (vr1) inhibitors useful for the treatment of pain or bladder function disorder |
| 05/02/2012 | EP1421389B1 Neurofibrillary labels |
| 05/01/2012 | US8168628 Conjugated psychotropic drugs and uses thereof |
| 05/01/2012 | CA2440794C Neurofibrillary labels |
| 04/19/2012 | WO2011036561A8 Process |
| 04/19/2012 | US20120094984 Fused aminodihydrothiazine derivatives |
| 04/19/2012 | US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 04/17/2012 | US8158620 Fused aminodihydrothiazine derivatives |
| 04/12/2012 | WO2012046869A1 Cyclic amide derivative |
| 04/12/2012 | US20120088759 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists |
| 04/12/2012 | CA2813639A1 Cyclic amide derivative |
| 04/11/2012 | CN101379044B 用于治疗糖尿病的杂双环磺酰胺衍生物 For the treatment of diabetes heterobicyclic sulfonamide derivatives |
| 04/05/2012 | US20120083489 Bis-pyridylpyridones as melanin-concentrating hormone receptor antagonists |
| 04/04/2012 | CN102405215A 吩噻嗪化合物阳离子基团的稳定方法、用于预防皮肤疾病和紊乱的药妆制剂和方法 Phenothiazines stabilization method triazine compound cationic groups, drug and cosmetic formulations and methods for the prevention of skin diseases and disorders |
| 04/03/2012 | US8148565 Method of manufacturing an organic silicon compound that contains a methacryloxy group or an acryloxy group |
| 03/29/2012 | WO2012040599A1 Radically polymerizable phenothiazine macromonomer for use in the coating of medical devices |
| 03/21/2012 | EP2431359A1 Process for preparing diaminophenothiazinium compounds |
| 03/21/2012 | EP2430007A1 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants |
| 03/21/2012 | EP2325169A9 Lisofylline analogues and their pharmeacuetical uses |
| 03/21/2012 | EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 03/21/2012 | EP1984345B9 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 03/21/2012 | CN101466694B Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/21/2012 | CN101379048B Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 03/20/2012 | US8138339 Inhibitors of protein kinases |
| 03/20/2012 | US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 03/15/2012 | US20120065195 Compounds for treating neurodegenerative diseases |
| 03/14/2012 | CN101891705B 4-alkyl-6-aryl-2-acylamino-1,3-thiazine-5-formic ether, and preparation method and application thereof |
| 03/08/2012 | US20120058995 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants |
| 03/08/2012 | DE102011053114A1 Verfahren zur Diagnose oder Prädiagnose einer beta-Amyloidopathie oder alpha-Synucleopathie Method for the diagnosis or pre-diagnosis of beta-Amyloidopathie or alpha-Synucleopathie |
| 03/07/2012 | CN102367239A 2-aryl-2,3-dihydro-4H-1,3-benzothiazine-4-ketone derivative and application thereof |
| 03/06/2012 | US8129358 Substituted pyrazole and triazole compounds as KSP inhibitors |
| 03/01/2012 | US20120053237 Oligomer-Amino Acid Conjugates |
| 02/29/2012 | CN101273995B Method for preparing magnetic particles modified by afi-tiazin dyes |
| 02/28/2012 | US8124603 In vivo studies of crystalline forms of meloxicam |
| 02/23/2012 | US20120046279 Oligomer-Phenothiazine Conjugates |
| 02/22/2012 | EP2420493A1 Haloalkylsulfonanilide derivative |
| 02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
| 02/16/2012 | US20120041194 Nitrogen and sulfur-containing hetrocycle derivatives |
| 02/09/2012 | US20120035163 Novel fused ring compound and use thereof |
| 02/09/2012 | US20120035162 Process for preparation of high-purity meloxicam and meloxicam potassium salt |
| 02/08/2012 | EP1409456B1 Detection of transmembrane potentials by optical methods |
| 02/02/2012 | US20120029187 Haloalkylsulfonanilide derivative |
| 01/31/2012 | CA2504718C Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/31/2012 | CA2447990C Encapsulation of nanosuspensions in liposomes and microspheres |
| 01/26/2012 | WO2012012139A1 Synthesis and use of kinase inhibitors |
| 01/26/2012 | WO2012009823A1 Tranquilising/sedating pharmaceutical formulation based on neurosteroids and a phenothiazine derivative for use in mammals |
| 01/26/2012 | US20120022249 Aminodihydrothiazine derivatives |
| 01/25/2012 | CN101107725B Phenothiazines, -s-oxides, and s,s-dioxides as well as phenoxazines as emitters for OLEDs |
| 01/19/2012 | US20120016116 Aminodihydrothiazine derivatives |
| 01/19/2012 | US20120013246 Dendrimer and organic light-emitting device using the same |
| 01/19/2012 | DE102010027218A1 Organische Komplexe enthaltend Metalle Organic complexes containing metals |
| 01/18/2012 | EP1429844B1 Conjugate of perphenazine and gaba and uses thereof |
| 01/17/2012 | US8097617 Organic compounds |
| 01/17/2012 | US8097615 Neurofibrillary labels |
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | US20120009519 Compound, resin and photoresist composition |
| 01/11/2012 | EP1915384B1 A method of manufacturing an organic silicon compound that contains a methacryloxy group or an acryloxy group |
| 01/11/2012 | EP1569904B1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/05/2012 | WO2012003189A1 Compositions and methods for modulating the wnt signaling pathway |
| 01/05/2012 | US20120003746 Method and kit for identification of an explosive substance which contains an oxidant |
| 01/05/2012 | CA2803879A1 Compositions and methods for modulating the wnt signaling pathway |
| 01/04/2012 | CN101565378B Preparation of derivative of dibenzoyl methane and application thereof |
| 01/03/2012 | US8088763 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/29/2011 | US20110319378 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 12/29/2011 | US20110319326 Derivatives of benzothiazines, preparation thereof and application thereof as drugs |
| 12/15/2011 | US20110306576 Compounds and methods relating thereto |
| 12/14/2011 | CN102276598A 苯并噻嗪硫酮衍生物及其制备方法和用途 Benzothiazine-thione derivatives and their preparation and use |
| 12/08/2011 | WO2011153509A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 12/08/2011 | US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 12/08/2011 | CA2799972A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 12/07/2011 | EP2392567A1 Benzothiazine derivatives and their use as lxr modulators |
| 12/07/2011 | EP2391601A1 Sulfamoyl- phenyl-ureido benzamidine-derivatives as antimalarial agents |
| 12/06/2011 | US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 12/01/2011 | WO2011150155A1 Polymer bonded redox molecules and methods of making the same |
| 12/01/2011 | US20110294795 Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| 12/01/2011 | US20110294787 Substituted thiomorpholine derivatives |
| 12/01/2011 | US20110294783 Insecticidal Compositions Having Improved Effect |
| 11/30/2011 | EP2389371A2 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 11/24/2011 | WO2011036558A3 Crystalline methylthionium chloride (methylene blue) hydrates |
| 11/24/2011 | US20110288292 Materials for organic electroluminescence devices |
| 11/24/2011 | US20110288080 Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis |
| 11/22/2011 | US8063205 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue |
| 11/15/2011 | US8058210 Arylphenyl-substituted cyclic keto-enols |
| 11/15/2011 | CA2477414C Novel fused ring compounds, and their use as cationic photoinitiators |
| 11/10/2011 | US20110275619 Inhibitors of bace1 and methods for treating alzheimer's disease |
| 11/03/2011 | US20110269953 Nitrogen and Sulfur-Containing Heterocycle Derivatives |
| 11/02/2011 | EP2382197A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 10/27/2011 | WO2011132070A1 Process for the preparation of 2-amino-substituted 1,3-benzothiazine-4-ones |
| 10/27/2011 | US20110262361 effective new drug target for the treatment of tuberculosis |
| 10/26/2011 | EP2380886A1 Process for the preparation of 2-aminosubstituted 1,3-benzothiazine-4-ones |
| 10/26/2011 | EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials |
| 10/26/2011 | CN102227486A Organic electroluminscent device using electroluminescent compounds |
| 10/26/2011 | CN101519387B Thiophenylamine derivative two-photon biological developing material |
| 10/19/2011 | EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors |
| 10/19/2011 | CN102224423A Ligands for aggregated tau molecules |
| 10/13/2011 | US20110251185 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |